Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other S&P 500 stocks. 2024 was a memorable year for the broad market index ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...

I cover careers, strategic leadership and executive development. Get rid of DEI policies? We’re too far down the road for that. The proof is in the pudding. The research and findings are clear.

But DEI backers, including most top US companies, believe a push for diversity has been good for their businesses. Trump did not cite any evidence for how efforts to hire more minorities ...

Attacking DEI before anyone knows what happened creates a pre-emptive scapegoat scenario. If anyone flying the plane or the helicopter or directing those aircraft at Reagan National Airport tower ...